Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Clene Inc (CLNN)

Clene Inc (CLNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clene Inc 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121 USA

https://clene.com P: 801-676-9695

Description:

Clene Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of unique therapeutics for neurodegenerative diseases. Clene Nanomedicine Inc., formerly known as Tottenham Acquisition I Limited, is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 47,777
Enterprise Value, $K 20,847
Shares Outstanding, K 128,434
Annual Sales, $ 650 K
Annual Net Income, $ -49,500 K
Last Quarter Sales, $ 70 K
Last Quarter Net Income, $ -11,080 K
EBIT, $ -39,040 K
EBITDA, $ -37,330 K
60-Month Beta 0.47
% of Insider Shareholders 25.10%
% of Institutional Shareholders 23.28%
Float, K 96,197
% Float 74.90%
Short Volume Ratio 0.36

Growth:

1-Year Return -60.20%
3-Year Return -96.74%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -65.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 05/08/24
Next Earnings Date 05/10/24
Earnings Per Share ttm -0.29
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year 40.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CLNN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -224.28%
Return-on-Assets % -60.21%
Profit Margin % -7,615.38%
Debt/Equity 0.43
Price/Sales 72.66
Price/Cash Flow N/A
Price/Book 11.61
Book Value/Share 0.03
Interest Coverage -9.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar